New scan could spot hidden kidney cancer after treatment
NCT ID NCT07077083
Summary
This study is testing whether a new type of PET scan using a special tracer called 89Zr-girentuximab can better detect leftover or returning kidney cancer after initial treatment. Researchers want to see if this scan is more accurate than current imaging methods at finding cancer that remains or comes back. The study involves 10 adults with clear cell renal cell carcinoma who will receive the tracer injection followed by PET scans.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CLEAR CELL RENAL CELL CARCINOMA (CCRCC) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Massachusetts General Hospital
Boston, Massachusetts, 02114, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.